3 deals
Pharma giant Pfizer wins over telehealth startup ResApp Health with $179 million takeover
Pfizer has completed its takeover of ASX-listed telehealth diagnostics company ResApp Health for $179 million, with the article recalling the company's 2015 listing, earlier raises and a Gates Foundation grant.